7Baggers
 roth capital issues optimistic estimate for polypid earnings  Defense World Mon, 17 Nov 2025 06:52:01 GMT
 published on: 2025-11-16 12:50:26  newser.com Sun, 16 Nov 2025 18:50:26 GMT
 Will PolyPid Ltd. stock outperform growth indexes - Buy Signal & AI Driven Stock Reports  Fundação Cultural do Pará Fri, 14 Nov 2025 14:24:28 GMT
 published on: 2025-11-13 18:14:47  newser.com Fri, 14 Nov 2025 00:14:47 GMT
 Roth Capital Maintains PolyPid (PYPD) Buy Recommendation  Nasdaq Fri, 14 Nov 2025 00:05:00 GMT
 PolyPid (PYPD) Sees Price Target Cut by Roth Capital | PYPD Stoc  GuruFocus Thu, 13 Nov 2025 17:09:46 GMT
 PolyPid Ltd. (NASDAQ:PYPD) Q3 2025 Earnings Call Transcript  Insider Monkey Thu, 13 Nov 2025 13:18:53 GMT
 PolyPid price target lowered to $9 from $10 at Roth Capital  TipRanks Thu, 13 Nov 2025 12:28:29 GMT
 PolyPid Ltd. Advances Towards Key Milestones in 2025  TipRanks Thu, 13 Nov 2025 04:06:28 GMT
 Published on: 2025-11-12 21:51:34  newser.com Thu, 13 Nov 2025 03:51:34 GMT
 PolyPid Ltd. Earnings Call: Progress and Potential  TipRanks Thu, 13 Nov 2025 00:11:34 GMT
 Earnings call transcript: PolyPid Q3 2025 shows mixed results, stock dips  Investing.com Nigeria Wed, 12 Nov 2025 18:03:46 GMT
 Transcript : PolyPid Ltd., Q3 2025 Earnings Call, Nov 12, 2025  MarketScreener Wed, 12 Nov 2025 17:52:11 GMT
 PolyPid : Investor Presentation (29305a)  MarketScreener Wed, 12 Nov 2025 15:14:10 GMT
 PolyPid Keeps Moving Forward Despite Quarterly Losses  Finimize Wed, 12 Nov 2025 13:48:22 GMT
 PolyPid sees cash runway ‘well into’ 2026  TipRanks Wed, 12 Nov 2025 13:08:04 GMT
 PolyPid reports Q3 EPS (37c), consensus (52c)  TipRanks Wed, 12 Nov 2025 12:48:04 GMT
 Biopharma firm PolyPid's Q3 net loss narrows to $7.5 mln  TradingView Wed, 12 Nov 2025 12:38:19 GMT
 PolyPid receives Nasdaq’s non-compliance letter  MSN Tue, 11 Nov 2025 20:02:20 GMT
 published on: 2025-11-10 05:44:52  newser.com Mon, 10 Nov 2025 11:44:52 GMT
 polypid (pypd) expected to announce earnings on wednesday  Defense World Mon, 10 Nov 2025 07:42:58 GMT
 published on: 2025-11-09 12:58:58  newser.com Sun, 09 Nov 2025 18:58:58 GMT
 polypid (nasdaq:pypd) cut to “sell” at wall street zen  Defense World Sat, 08 Nov 2025 09:36:08 GMT
 polypid receives nasdaq’s non-compliance letter  MSN Sat, 08 Nov 2025 01:33:55 GMT
 published on: 2025-11-06 06:18:06  newser.com Thu, 06 Nov 2025 12:18:06 GMT
 published on: 2025-11-06 04:13:33  newser.com Thu, 06 Nov 2025 10:13:33 GMT
 polypid ltd. (pypd) analyst insights, price targets and recommendations  Yahoo! Finance UK Tue, 04 Nov 2025 00:25:40 GMT
 polypid ltd. (nasdaq:pypd) sees significant increase in short interest  Defense World Mon, 03 Nov 2025 00:48:08 GMT
 published on: 2025-10-30 23:33:37  newser.com Fri, 31 Oct 2025 04:33:37 GMT

PolyPid Ltd
(NASDAQ:PYPD) 

PYPD stock logo

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) s...

Founded: 2008
Full Time Employees: 57
CEO: Amir Weisberg  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends